Viral reactivation from ganglia in subarachnoid hemorrhage
蛛网膜下腔出血中神经节的病毒再激活
基本信息
- 批准号:10242954
- 负责人:
- 金额:$ 7.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdmission activityAdrenergic AgentsAnatomyAneurysmal Subarachnoid HemorrhagesAntiviral AgentsAutonomic PathwaysAutonomic ganglionBlood Flow VelocityBlood VesselsBrainCaliberCatecholaminesCerebral IschemiaCerebrovascular SpasmCerebrovascular systemCerebrumCessation of lifeClinical ManagementCollectionComplicationDetectionDevelopmentDigital Subtraction AngiographyDiseaseEpinephrineEyeFutureGangliaGlandHead and neck structureHemorrhageHerpesviridaeHerpesvirus 1HospitalizationIncidenceIndividualLinkLiteratureMeasurementMethodsMonitorMorbidity - disease rateNerveNerve FibersNorepinephrineOralOral cavityPathway interactionsPatientsPerfusionPeripheralPrevention approachReportingResearch PersonnelRiskSalivaSamplingSerumSpecimenSubarachnoid HemorrhageSurfaceSympathetic GangliaSympathetic Nervous SystemTestingTimeVasospasmViralVirus SheddingVisceraafferent nerveautonomic nervefunctional outcomesintracranial arterymortalitynovel strategiespredictive markerpreventreactivated HSV-1responserisk stratification
项目摘要
Project Summary
Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating disease frequently leading
to death or poor functional outcome. A major complication of aSAH is the development of
cerebral vasospasm, which is defined as narrowing of the large and medium-sized
intracranial arteries. Between 30-70% of patients develop vasospasm after aSAH and half
of these may develop symptomatic delayed cerebral ischemia (DCI) with the incidence
peaking in the second week after ictus. Despite improvements in the clinical management
of aSAH over the last decade, DCI remains the single most important cause of morbidity
and mortality in those patients who survive the initial hemorrhage.
Limited information exists regarding underlying anatomic mechanisms of vasospasm in
aSAH. Cerebral blood vessels on the surface of the brain are surrounded by nerve fibers
that originate from sensory and autonomic nerve ganglia that are highly sensitive to
sympathetic nervous system activity. Elevated levels of catecholamines have been well
documented in aSAH, and in the acute setting, activation of perivascular sympathetic
nerves leads to an increase in vascular tone and as a result, decreases brain perfusion.
Paroxysmal cerebral vasospasm outside the acute setting suggests a different or delayed
mechanism perhaps through the same anatomic pathway.
We propose that herpesvirus reactivation in response to adrenergic activation of head and
neck ganglia during aSAH will be directly related and thus temporally correlated with the
occurrence of cerebral vasospasm. Given the shared anatomic pathways between glands,
viscera and cerebral blood vessels, we propose that non-invasive, simultaneous
monitoring of vascular tone and viral shedding from glandular secretions could
demonstrate a correlation between viral reactivation and vasospasm after aSAH. If correct,
antiviral agents would have the potential to reduce or prevent DCI in individuals with aSAH
and analysis of oral and ocular secretions after acute aSAH may provide a simple and
non-invasive predictive biomarker to assess risk of developing vasospasm.
项目概要
动脉瘤性蛛网膜下腔出血 (aSAH) 是一种破坏性疾病,经常导致
导致死亡或功能不良。 aSAH 的一个主要并发症是
脑血管痉挛,定义为大中型脑血管狭窄
颅内动脉。 30-70% 的患者在 aSAH 后出现血管痉挛,半数患者出现血管痉挛
这些人中的一些人可能会出现症状性迟发性脑缺血(DCI),其发病率
发作后第二周达到高峰。尽管临床管理有所改善
过去十年中,DCI 仍然是导致 aSAH 发病的最重要原因
以及那些在最初的出血中幸存下来的患者的死亡率。
关于血管痉挛的潜在解剖机制的信息有限
萨哈。大脑表面的脑血管被神经纤维包围
起源于对感觉和自主神经节高度敏感的
交感神经系统活动。儿茶酚胺水平升高
据记录,在 aSAH 中,以及在急性情况下,血管周围交感神经的激活
神经导致血管张力增加,从而减少大脑灌注。
急性环境之外的阵发性脑血管痉挛提示不同的或延迟的
机制可能通过相同的解剖途径。
我们提出,疱疹病毒重新激活是对头部和头部肾上腺素能激活的反应。
aSAH 期间的颈部神经节将直接相关,因此在时间上与
脑血管痉挛的发生。鉴于腺体之间共享的解剖通路,
内脏和脑血管,我们建议非侵入性、同步
监测血管张力和腺体分泌物的病毒脱落可以
证明 aSAH 后病毒再激活与血管痉挛之间存在相关性。如果正确的话,
抗病毒药物有可能减少或预防 aSAH 患者的 DCI
急性 aSAH 后口腔和眼部分泌物的分析可能提供简单且可靠的方法
用于评估发生血管痉挛风险的非侵入性预测生物标志物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melanie Walker其他文献
Melanie Walker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Perioperative Medication Use, Post-operative Delirium, and Cognition in Older Adults Undergoing Elective Non-Cardiac Surgery
接受择期非心脏手术的老年人围手术期药物使用、术后谵妄和认知
- 批准号:
9911310 - 财政年份:2019
- 资助金额:
$ 7.78万 - 项目类别:
Interleukin-1 blockade in recently decompensated heart failure
近期失代偿性心力衰竭中的 IL-1 阻断
- 批准号:
8725731 - 财政年份:2013
- 资助金额:
$ 7.78万 - 项目类别:
Interleukin-1 blockade in recently decompensated heart failure
近期失代偿性心力衰竭中的 IL-1 阻断
- 批准号:
8583175 - 财政年份:2013
- 资助金额:
$ 7.78万 - 项目类别: